Population-based incidence of human metapneumovirus infection among hospitalized children
- PMID: 20446850
- PMCID: PMC2873123
- DOI: 10.1086/652782
Population-based incidence of human metapneumovirus infection among hospitalized children
Abstract
Background: Human metapneumovirus (HMPV) is a leading cause of acute respiratory illness (ARI) in children. Population-based incidence rates and comprehensive clinical characterizations of disease have not been established.
Methods: We conducted population-based prospective surveillance for 2 years in 2 US counties of HMPV infection among children <5 years old who were hospitalized with ARI or fever. Nasal and throat specimens obtained with swabs were tested for HMPV by real-time reverse-transcription polymerase chain reaction and genotyped.
Results: Forty-two (3.8%) of 1104 children tested positive for HMPV. The overall annual rate of HMPV-associated hospitalizations per 1000 children <5 years old was 1.2 (95% confidence interval [CI], 0.9-1.6). This rate was highest among infants 0-5 months old (4.9 per 1000 [95% CI, 2.9-7.2]), followed by children 6-11 months old (2.9 per 1000 [95% CI, 1.4-4.7]). The annual rate of hospitalization for HMPV infection was less than that for respiratory syncytial virus infection but similar to that for influenza and parainfluenza virus 3 infection in all age groups. The mean age of children hospitalized with HMPV infection was 6 months. Bronchiolitis, pneumonia, and asthma were the most common diagnoses among children with HMPV infection. All 4 HMPV subgroups were detected during both years at both sites. HPMV infection was most prominent from March through May.
Conclusion: HMPV was detected in 3.8% of children hospitalized with ARI or fever, with a population incidence similar to that of influenza virus and parainfluenza virus 3.
Conflict of interest statement
Potential conflicts of interest: J.V.W. has served as a consultant for MedImmune and Novartis. K.M.E. receives research funding from Sanofi-Pasteur, Wyeth, Novartis, and CSL. G.A.W. has served as a consultant for MedImmune. M.R.G. has received research funding from MedImmune and Merck. C.B.H. has served as a consultant for and received research support from MedImmune. J.E.C. has served as a consultant for Anaptys, Immunobiosciences, Mapp, MedImmune, and Novartis and has received research support from MedImmune, Mapp, Alnylam, and Sanofi-Pasteur. C.K.W., C.-F.Y., D.S., D.Y., and R.R.S. were employees of MedImmune at the time of this study. All other authors report no potential conflicts.
Figures
Comment in
-
Human metapneumovirus infection as an emerging pathogen causing acute respiratory distress syndrome.J Infect Dis. 2011 Jan 15;203(2):294-5; author reply 296. doi: 10.1093/infdis/jiq045. J Infect Dis. 2011. PMID: 21288832 Free PMC article. No abstract available.
Similar articles
-
Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.Pediatr Infect Dis J. 2008 May;27(5):406-12. doi: 10.1097/INF.0b013e318162a164. Pediatr Infect Dis J. 2008. PMID: 18382388
-
Human metapneumovirus in hospitalized children less than 5 years of age in Pakistan.J Med Virol. 2018 Jun;90(6):1027-1032. doi: 10.1002/jmv.25044. Epub 2018 Mar 12. J Med Virol. 2018. PMID: 29424432
-
Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala.Influenza Other Respir Viruses. 2014 Jul;8(4):414-21. doi: 10.1111/irv.12251. Epub 2014 Apr 25. Influenza Other Respir Viruses. 2014. PMID: 24761765 Free PMC article.
-
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis.J Clin Virol. 2016 Aug;81:68-77. doi: 10.1016/j.jcv.2016.05.015. Epub 2016 Jun 7. J Clin Virol. 2016. PMID: 27337518 Free PMC article. Review.
-
Human metapneumovirus.Clin Lab Med. 2010 Mar;30(1):131-48. doi: 10.1016/j.cll.2009.10.002. Clin Lab Med. 2010. PMID: 20513544 Free PMC article. Review.
Cited by
-
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice.Viruses. 2024 Jul 6;16(7):1087. doi: 10.3390/v16071087. Viruses. 2024. PMID: 39066249 Free PMC article.
-
Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer.Nat Commun. 2024 Jul 25;15(1):6270. doi: 10.1038/s41467-024-50659-5. Nat Commun. 2024. PMID: 39054318 Free PMC article.
-
Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua.Influenza Other Respir Viruses. 2022 Nov;16(6):1112-1121. doi: 10.1111/irv.13034. Epub 2022 Aug 14. Influenza Other Respir Viruses. 2022. PMID: 35965382 Free PMC article.
-
Hospital utilization rates for influenza and RSV: a novel approach and critical assessment.Popul Health Metr. 2021 Jun 14;19(1):31. doi: 10.1186/s12963-021-00252-5. Popul Health Metr. 2021. PMID: 34126993 Free PMC article.
-
Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses.Viruses. 2021 May 29;13(6):1023. doi: 10.3390/v13061023. Viruses. 2021. PMID: 34072332 Free PMC article. Review.
References
-
- McAdam AJ, Hasenbein ME, Feldman HA, et al. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004;190:20–26. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
